Reportable Segment Information (Tables)

3 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended
	December 31,
(Dollars in thousands)	2015			2014
Revenue:
Medical Device	$	12,247		$	10,635
In Vitro Diagnostics		4,294			3,570
Total revenue	$	16,541		$	14,205
Operating income:
Medical Device	$	3,830		$	5,515
In Vitro Diagnostics		1,643			1,098
Total segment operating income		5,473			6,613
Corporate		(1,534	)		(1,579	)
Total operating income	$	3,939		$	5,034
Depreciation and amortization:
Medical Device	$	487		$	270
In Vitro Diagnostics		222			213
Corporate		200			200
Total depreciation and amortization	$	909		$	683